| Filed On | Filing |
|---|---|
| 07 Feb 2025 |
8-K/A: Departure/Election of Directors or Officers; Compensation
Pacific Biosciences of California, Inc. (the “Company”) is filing this amendment to its Current Report on Form 8-K filed on January 30, 2025, which reported that the Company’s Board of Directors (the “Board”) had appointed Christopher M.... |
| 13 Dec 2024 |
8-K/A: Departure/Election of Directors or Officers; Compensation
This Separation Agreement and Release (“Agreement”) is made by and between Jeff Eidel (“Employee”) and Pacific Biosciences of California, Inc. (the “Company”) (jointly referred to as the “Parties” or individually referred to as a “Party”). |
| 07 Aug 2024 |
8-K/A: Costs Associated with Exit or Disposal Activities
On April 16, 2024 Pacific Biosciences of California, Inc., a Delaware corporation (the “Company”) filed a Current Report on Form 8-K regarding a plan to reduce its annualized run-rate operating expenses to better align its organizational... |
| 27 Oct 2023 |
8-K/A: Departure/Election of Directors or Officers; Compensation
On October 24, 2023, the Board appointed Mr. Meline to its Audit Committee, effective October 24, 2023. |
| 22 Sep 2023 |
8-K/A: Unregistered Sales of Equity Securities
On September 20, 2023, the Company achieved the commercial milestone under the Merger Agreement. Consequently, pursuant to the Merger Agreement, former Omniome securityholders are entitled to receive as milestone consideration, among oth... |
| 16 Apr 2019 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
| 10 Mar 2015 | 8-K/A: Departure/Election of Directors or Officers; Compensation |
Loading...
